In vitro methods for peptide display and their applications

Briefings in Functional Genomics

Volumn 10, Issue 3, 2011, Pages 125-134

  Ullman, Christopher G ^a   Frigotto, Laura ^b   Cooley, R Neil ^a  

^a Isogenica Ltd   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

CIS display; In vitro display; Molecular evolution; Peptide display; Phage display; Ribosomal display

Indexed keywords

AMINO ACID; ANKYRIN; COAT PROTEIN; DNA BINDING PROTEIN; MESSENGER RNA; NANOMATERIAL; PEGINESATIDE; PEPTIDE LIBRARY; PLASMA KALLIKREIN; PUROMYCIN; RECOMBINANT PROTEIN; PEPTIDE;

ANEMIA; ARTICLE; CELL COMPARTMENTALIZATION; DISULFIDE BOND; DNA LIBRARY; ERYTHROCYTE APLASIA; ESCHERICHIA COLI; EUKARYOTIC CELL; GENE SEQUENCE; GENETIC CODE; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; IN VIVO STUDY; MEMBRANE PERMEABILITY; NONHUMAN; NONRIBOSOMAL PEPTIDE SYNTHESIS; PHAGE DISPLAY; PROKARYOTIC CELL; PROTEIN STABILITY; RIBOSOME; YEAST CELL; BACTERIOPHAGE; BIOLOGICAL MODEL; CHEMISTRY; METABOLISM; REVIEW;

AMINO ACIDS; BACTERIOPHAGES; MODELS, BIOLOGICAL; PEPTIDE LIBRARY; PEPTIDES;

EID: 80054780096     PISSN: 20412649     EISSN: 20412657     Source Type: Journal    
DOI: 10.1093/bfgp/elr010     Document Type: Article

References (100)

1. Smith GP, Petrenko VA. Phage display. Chem Rev 1997;97: 391-410.
2. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985;228:1315-7.
3. Parmley SF, Smith GP. Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene 1988;73:305-18.
4. Ullman C. The evolution of molecular display. Eur Biopharm Rev 2010;53:72-8.
5. Krumpe LR, Mori T. Potential of phage-displayed peptide library technology to identify functional targeting peptides. Expert Opin Drug Discov 2007;2:525.
6. Hoogenboom HR. Selecting and screening recombinant antibody libraries. Nat Biotechnol 2005;23:1105-6.
7. Sidhu SS. Phage display in pharmaceutical biotechnology. Curr Opin Biotechnol 2000;11:610-6.
8. Sergeeva A, Kolonin MG, Molldrem JJ, et al. Display technologies: application for the discovery of drug and gene delivery agents. Adv Drug Deliv Rev 2006;58:1622-54.
9. Bruckner A, Polge C, Lentze N, et al. Yeast two-hybrid, a powerful tool for systems biology. Int J Mol Sci 2009;10: 2763-88.
10. Mason J. Design and development of peptides and peptide mimetics as antagonists for therapeutic intervention. Future Med Chem 2010;2:1813-22.
11. Weiss GA, Wells JA, Sidhu SS. Mutational analysis of the major coat protein of M13 identifies residues that control protein display. Protein Sci 2000;9:647-54.
12. Weiss GA, Roth TA, Baldi PF, et al. Comprehensive mutagenesis of the C-terminal domain of the M13 gene-3 minor coat protein: the requirements for assembly into the bacteriophage particle. J Mol Biol 2003;332:777-82.
13. Held HA, Sidhu SS. Comprehensive mutational analysis of the M13 major coat protein: improved scaffolds for C-terminal phage display. J Mol Biol 2004;340:587-97.
14. Zahnd C, Spinelli S, Luginbuhl B, et al. Directed in vitro evolution and crystallographic analysis of a peptide-binding single chain antibody fragment (scFv) with low picomolar affinity. J Biol Chem 2004;279:18870-7.
15. Levin AM, Weiss GA. Optimizing the affinity and specificity of proteins with molecular display. Mol Biosyst 2006;2: 49-57.
16. Zahnd C, Sarkar CA, Pluckthun A. Computational analysis of off-rate selection experiments to optimize affinity maturation by directed evolution. Protein Eng Des Sel 2010;23: 175-84.
17. Mao C, Solis DJ, Reiss BD, et al. Virus-based toolkit for the directed synthesis of magnetic and semiconducting nanowires. Science 2004;303:213-7.
18. Sidhu SS, Lowman HB, Cunningham BC, et al. Phage display for selection of novel binding peptides. Methods Enzymol 2000;328:333-63.
19. Rothe A, Hosse RJ, Power BE. In vitro display technologies reveal novel biopharmaceutics. FASEB J 2006;20:1599-610.
20. Macdougall IC, Rossert J, Casadevall N, et al. A peptidebased erythropoietin-receptor agonist for pure red-cell aplasia. N Engl J Med 2009;361:1848-55.
21. Arap W, Kolonin MG, Trepel M, et al. Steps toward mapping the human vasculature by phage display. Nat Med 2002;8:121-7.
22. Giordano RJ, Cardo-Vila M, Salameh A, et al. From combinatorial peptide selection to drug prototype (I): Targeting the vascular endothelial growth factor receptor pathway. Proc Natl Acad Sci USA 2010;107:5112-7.
23. Chen Y, Shen Y, Guo X, etal. Transdermal protein delivery by a coadministered peptide identified via phage display. Nat Biotechnol 2006;24:455-60.
24. Frenkel D, Solomon B. Filamentous phage as vectormediated antibody delivery to the brain. Proc Natl Acad Sci USA 2002;99:5675-9.
25. Duerr DM, White SJ, Schluesener HJ. Identification of peptide sequences that induce the transport of phage across the gastrointestinal mucosal barrier. J Virol Methods 2004;116:177-80.
26. Gao C, Mao S, Ditzel HJ, et al. A cell-penetrating peptide from a novel pVII-pIX phage-displayed random peptide library. Bioorg Med Chem 2002;10:4057-65.
27. Kolmar H. Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins. CurrOpin Pharmacol 2009;9:608-14.
28. Chang HJ, Hsu HJ, Chang CF, et al. Molecular evolution of cystine-stabilized miniproteins as stable proteinaceous binders. Structure 2009;17:620-31.
29. Timmerman P, Beld J, Puijk WC, et al. Rapid and quantitative cyclization of multiple peptide loops onto synthetic scaffolds for structural mimicry of protein surfaces. Chembiochem 2005;6:821-4.
30. Heinis C, Rutherford T, Freund S, et al. Phage-encoded combinatorial chemical libraries based on bicyclic peptides. Nat Chem Biol 2009;5:502-7.
31. Hoogenboom HR, Chames P. Natural and designer binding sites made by phage display technology. Immunol Today 2000;21:371-8.
32. Hudson PJ, Souriau C. Engineered antibodies. Nat Med 2003;9:129-34.
33. Kretzschmar T, von Ruden T. Antibody discovery: phage display. Curr Opin Biotechnol 2002;13:598-602.
34. Hosse RJ, Rothe A, Power BE. A new generation of protein display scaffolds for molecular recognition. Protein Sci 2006;15:14-27.
35. Isalan M, Klug A, Choo Y. A rapid, generally applicable method to engineer zinc fingers illustrated by targeting the HIV-1 promoter. Nat Biotechnol 2001;19:656-60.
36. Moore M, Ullman C. Recent developments in the engineering of zinc finger proteins. Brief Funct Genomic Proteomic 2003;1:342-55.
37. Imai S, Mukai Y, Takeda T, et al. Effect of protein properties on display efficiency using the M13 phage display system. Pharmazie 2008;63:760-4.
38. Velappan N, Fisher HE, Pesavento E, et al. A comprehensive analysis of filamentous phage display vectors for cytoplasmic proteins: an analysis with different fluorescent proteins. Nucleic Acids Res 2010;38:e22.
39. Krumpe LR, Atkinson AJ, Smythers GW, et al. T7 lytic phage-displayed peptide libraries exhibit less sequence bias than M13 filamentous phage-displayed peptide libraries. Proteomics 2006;6:4210-22.
40. Gai SA, Wittrup KD. Yeast surface display for protein engineering and characterization. CurrOpin Struct Biol 2007;17: 467-73.
41. Bowley DR, Labrijn AF, Zwick MB, etal. Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage. Protein Eng Des Sel 2007;20:81-90.
42. Bessette PH, Rice JJ, Daugherty PS. Rapid isolation of high-affinity protein binding peptides using bacterial display. Protein Eng Des Sel 2004;17:731-9.
43. Rockberg J, Lofblom J, Hjelm B, et al. Epitope mapping of antibodies using bacterial surface display. Nat Methods 2008; 5:1039-45.
44. Daugherty PS. Protein engineering with bacterial display. Curr Opin Struct Biol 2007;17:474-80.
45. Kenrick SA, Daugherty PS. Bacterial display enables efficient and quantitative peptide affinity maturation. Protein Eng Des Sel 2010;23:9-17.
46. Ling MM. Large antibody display libraries for isolation of high-affinity antibodies. Comb Chem HighThroughput Screen 2003;6:421-32.
47. Chodorge M, Fourage L, Ravot G, et al. In vitro DNA recombination by L-Shuffling during ribosome display affinity maturation of an anti-Fas antibody increases the population of improved variants. Protein Eng Des Sel 2008; 21:343-51.
48. Mattheakis LC, Bhatt RR, Dower WJ. An in vitro polysome display system for identifying ligands from very large peptide libraries. Proc Natl Acad Sci USA 1994;91:9022-6.
49. Hanes J, Pluckthun A. In vitro selection and evolution of functional proteins by using ribosome display. Proc Natl Acad Sci USA 1997;94:4937-42.
50. He M, Taussig MJ. Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites. Nucleic Acids Res 1997;25:5132-4.
51. Hanes J, Jermutus L, Schaffitzel C, et al. Comparison of Escherichia coli and rabbit reticulocyte ribosome display systems. FEBS Lett 1999;450:105-10.
52. He M, Taussig MJ. Ribosome display: cell-free protein display technology. BriefFunctGenomicProteomic 2002;1:204-12.
53. Shimizu Y, Kanamori T, Ueda T. Protein synthesis by pure translation systems. Methods 2005;36:299-304.
54. Shimizu Y, Inoue A, Tomari Y, et al. Cell-free translation reconstituted with purified components. Nat Biotechnol 2001;19:751-5.
55. Villemagne D, Jackson R, Douthwaite JA. Highly efficient ribosome display selection by use of purified components for in vitro translation. J Immunol Methods 2006;313:140-8.
56. Jermutus L, Honegger A, Schwesinger F, et al. Tailoring in vitro evolution for protein affinity or stability. Proc Natl Acad Sci USA 2001;98:75-80.
57. Nakajima E, Goto Y, Sako Y, et al. Ribosomal synthesis of peptides with C-terminal lactams, thiolactones, and alkylamides. Chembiochem 2009;10:1186-92.
58. Bonetto S, Spadola L, Buchanan AG, et al. Identification of cyclic peptides able to mimic the functional epitope of IgG1-Fc for human Fc gammaRI. FASEBJ 2009;23:575-85.
59. Thom G, Cockroft AC, Buchanan AG, et al. Probing a protein-protein interaction by in vitro evolution. Proc Natl Acad Sci USA 2006;103:7619-24.
60. Zahnd C, Amstutz P, Pluckthun A. Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target. Nat Meth 2007;4:269-79.
61. Irving RA, Coia G, Roberts A, et al. Ribosome display and affinity maturation: from antibodies to single V-domains and steps towards cancer therapeutics. J Immunol Methods 2001;248:31-45.
62. Douthwaite JA, Groves MA, Dufner P, et al. An improved method for an efficient and easily accessible eukaryotic ribosome display technology. Protein Eng Des Sel 2006;19:85-90.
63. Nemoto N, Miyamoto-Sato E, Husimi Y, et al. In vitro virus: bonding of mRNA bearing puromycin at the 30-terminal end to the C-terminal end of its encoded protein on the ribosome in vitro. FEBS Lett 1997;414:405-8.
64. Roberts RW, Szostak JW. RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc Natl Acad Sci USA 1997;94:12297-302.
65. Wilson DS, Keefe AD, Szostak JW. The use of mRNA display to select high-affinity protein-binding peptides. ProcNatl Acad Sci USA 2001;98:3750-5.
66. Takahashi TT, Austin RJ, Roberts RW. mRNA display: ligand discovery, interaction analysis and beyond. Trends Biochem Sci 2003;28:159-65.
67. Millward SW, Fiacco S, Austin RJ, et al. Design of cyclic peptides that bind protein surfaces with antibody-like affinity. ACS Chem Biol 2007;2:625-34.
68. Li S, Millward S, Roberts R. In vitro selection of mRNA display libraries containing an unnatural amino acid. J Am Chem Soc 2002;124:9972-3.
69. Hammond PW, Alpin J, Rise CE, et al. In vitro selection and characterization of Bcl-X(L)-binding proteins from a mix of tissue-specific mRNA display libraries. J Biol Chem 2001;276:20898-906.
70. Keefe AD, Szostak JW. Functional proteins from a random-sequence library. Nature 2001;410:715-8.
71. Yamaguchi J, Naimuddin M, Biyani M, etal. cDNA display: a novel screening method for functional disulfide-rich peptides by solid-phase synthesis and stabilization of mRNAprotein fusions. Nucleic Acids Res 2009;37:e108.
72. Odegrip R, Coomber D, Eldridge B, et al. CIS display: In vitro selection of peptides from libraries of protein-DNA complexes. Proc Natl Acad Sci USA 2004;101: 2806-10.
73. Reichert JM, Jacob N, Amanullah A. Second International Conference on Accelerating Biopharmaceutical Development: 9-12 March 2009, Coronado, CAUSA, MAbs 2009;1:190-209.
74. Eldridge B, Cooley RN, Odegrip R, et al. An in vitro selection strategy for conferring protease resistance to ligand binding peptides. Protein Eng Des Sel 2009;22:691-8.
75. Coomber DFK, Mcgregor D, Ullman C, Leanderson T. Membrane Translocating Peptides. GB: UK Intellectual Property Office, Isogenica Ltd, 2007.
76. Reiersen H, Lobersli I, Loset GA, et al. Covalent antibody display-an in vitro antibody-DNA library selection system. Nucleic Acids Res 2005;33:e10.
77. Tawfik DS, Griffiths AD. Man-made cell-like compartments for molecular evolution. Nat Biotechnol 1998;16: 652-6.
78. Fernandez-Gacio A, Uguen M, Fastrez J. Phage display as a tool for the directed evolution of enzymes. Trends Biotechnol 2003;21:408-14.
79. Sepp A, Tawfik DS, Griffiths AD. Microbead display by in vitro compartmentalisation: selection for binding using flow cytometry. FEBS Lett 2002;532:455-8.
80. Griffiths AD, Tawfik DS. Directed evolution of an extremely fast phosphotriesterase by in vitro compartmentalization. EMBOJ 2003;22:24-35.
81. Bertschinger J, Grabulovski D, Neri D. Selection of single domain binding proteins by covalent DNA display. Protein Eng Des Sel 2007;20:57-68.
82. Doi N, Yanagawa H. STABLE: protein-DNA fusion system for screening of combinatorial protein libraries in vitro. FEBS Lett 1999;457:227-30.
83. Kang TJ, Suga H. Ribosomal synthesis of nonstandard peptides. Biochem Cell Biol 2008;86:92-9.
84. Frankel A, Li S, Starck SR, et al. Unnatural RNA display libraries. Curr Opin Struct Biol 2003;13:506-12.
85. Hendrickson TL, de Crecy-Lagard V, Schimmel P. Incorporation of nonnatural amino acids into proteins. Annu Rev Biochem 2004;73:147-76.
86. Liu CC, Mack AV, Brustad EM, et al. Evolution of proteins with genetically encoded 'chemical warheads'. J Am Chem Soc 2009;131:9616-7.
87. Liu CC, Mack AV, Tsao ML, et al. Protein evolution with an expanded genetic code. Proc Natl Acad Sci USA 2008;105: 17688-93.
88. Funke SA, Willbold D. Mirror image phage display-a method to generate D-peptide ligands for use in diagnostic or therapeutical applications. Mol Biosyst 2009;5:783-6.
89. Welch BD, VanDemark AP, Heroux A, et al. Potent D-peptide inhibitors of HIV-1 entry. Proc Natl Acad Sci USA 2007;104:16828-33.
90. Welch BD, Francis JN, Redman JS, et al. Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistance. J Virol 2010;84:11235-44.
91. Noren CJ, Anthony-Cahill SJ, Griffith MC, et al. A general method for site-specific incorporation of unnatural amino acids into proteins. Science 1989;244:182-8.
92. Ohtsuki T, Manabe T, Sisido M. Multiple incorporation of non-natural amino acids into a single protein using tRNAs with non-standard structures. FEBS Lett 2005;579:6769-74.
93. Neumann H, Wang K, Davis L, et al. Encoding multiple unnatural amino acids via evolution of a quadrupletdecoding ribosome. Nature 2010;464:441-4.
94. Kang TJ, Yuzawa S, Suga H. Expression of histone H3 tails with combinatorial lysine modifications under the reprogrammed genetic code for the investigation on epigenetic markers. Chem Biol 2008;15:1166-74.
95. Kang TJ, Suga H. In vitro selection of a 50-purine ribonucleotide transferase ribozyme. Nucleic Acids Res 2007;35: 4186-94.
96. Watt PM. Screening for peptide drugs from the natural repertoire of biodiverse protein folds. Nat Biotechnol 2006; 24:177-83.
97. Sako Y, Goto Y, Murakami H, et al. Ribosomal synthesis of peptidase-resistant peptides closed by a nonreducible inter-side-chain bond. ACS Chem Biol 2008;3:241-9.
98. McGregor DP. Discovering and improving novel peptide therapeutics. Curr Opin Pharmacol 2008;8:616-9.
99. Dias-Neto E, Nunes DN, Giordano RJ, et al. Next-generation phage display: integrating and comparing available molecular tools to enable cost-effective highthroughput analysis. PLoS One 2009;4:e8338.
100. Li W, Caberoy NB. New perspective for phage display as an efficient and versatile technology of functional proteomics. Appl Microbiol Biotechnol 2010;85:909-19.